The OX40-TRAF6 axis promotes CTLA-4 degradation to augment antitumor CD8+ T-cell immunity.
Yu J, Cui J, Zhang X, Xu H, Chen Z, Li Y, Niu Y, Wang S, Ran S, Zou Y, Ye W, Zhang D, Zhou C, Xia J, Wu J.
Yu J, et al.
Cell Mol Immunol. 2023 Dec;20(12):1445-1456. doi: 10.1038/s41423-023-01093-y. Epub 2023 Nov 7.
Cell Mol Immunol. 2023.
PMID: 37932534